Growth Metrics

GoodRx Holdings (GDRX) Retained Earnings (2019 - 2025)

Historic Retained Earnings for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to -$1.4 billion.

  • GoodRx Holdings' Retained Earnings rose 219.33% to -$1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.4 billion, marking a year-over-year increase of 219.33%. This contributed to the annual value of -$1.4 billion for FY2024, which is 112.46% up from last year.
  • According to the latest figures from Q3 2025, GoodRx Holdings' Retained Earnings is -$1.4 billion, which was up 219.33% from -$1.4 billion recorded in Q2 2025.
  • GoodRx Holdings' 5-year Retained Earnings high stood at -$1.4 billion for Q2 2021, and its period low was -$1.5 billion during Q1 2024.
  • Over the past 5 years, GoodRx Holdings' median Retained Earnings value was -$1.4 billion (recorded in 2025), while the average stood at -$1.4 billion.
  • As far as peak fluctuations go, GoodRx Holdings' Retained Earnings tumbled by 2596.77% in 2021, and later skyrocketed by 238.34% in 2025.
  • Over the past 5 years, GoodRx Holdings' Retained Earnings (Quarter) stood at -$1.4 billion in 2021, then dropped by 2.32% to -$1.4 billion in 2022, then fell by 0.61% to -$1.5 billion in 2023, then rose by 1.12% to -$1.4 billion in 2024, then increased by 1.74% to -$1.4 billion in 2025.
  • Its Retained Earnings was -$1.4 billion in Q3 2025, compared to -$1.4 billion in Q2 2025 and -$1.4 billion in Q1 2025.